Skip to main content
. 2009 Oct 26;95(1):151–158. doi: 10.1210/jc.2009-0358

Table 1.

Study subject characteristics

Characteristic Pbo-P TPTD-P 20-μg TPTD-P 30-μg TPTD-P 40-μg TPTD-I 20-μg
n 33 34 32 33 33
Age (yr) 64.8 (7.1) 64.1 (7.5) 63.6 (5.8) 64.6 (7.3) 63.2 (6.8)
Weight (kg) 63.2 (9.4) 59.1 (9.2) 58.6 (7.8) 62.0 (9.9) 63.0 (9.5)
Height (cm) 154 (6.2) 152 (7.3) 154 (6.8) 156 (7.5) 152 (7.7)
Race (%)a
 Caucasian 12.1 26.5 31.3 42.4 24.2
 Hispanic 87.9 73.5 68.8 57.6 72.7
 Asian 3
Vertebral fractures 8 6 4 7 8
T-score
 LS −3.2 (0.7) −3.0 (0.5) −3.2 (0.5) −3.2 (0.7) −3.0 (0.6)
 Total hip −1.6 (0.7) −1.5 (0.7) −1.7 (0.5) −1.8 (0.7) −1.7 (0.6)
BMD (gm/cm2)
 LS 0.71 (0.1) 0.74 (0.1) 0.72 (0.1) 0.74 (0.1) 0.74 (0.1)
 Total hip 0.70 (0.1) 0.70 (0.09) 0.74 (0.1) 0.73 (0.1) 0.75 (0.1)
 Femoral neck 0.60 (0.1) 0.60 (0.1) 0.63 (0.1) 0.64 (0.1) 0.65 (0.1)
Biomarkers
 P1NP (ng/ml) 49.5 (19.4) 45.7 (22.0) 43.9 (17.6) 42.2 (19.6) 45.8 (19.1)
 CTX (ng/ml) 0.60 (0.3) 0.62 (0.3) 0.63 (0.2) 0.65 (0.4) 0.65 (0.3)
 Total serum calcium (mg/dl) 9.4 (0.5) 9.6 (0.5) 9.3 (0.5) 9.5 (0.5) 9.6 (0.4)

All values are expressed as mean (sd) unless otherwise stated. 

a

There was no statistical difference among any of the groups. For race, P < 0.1.